Jan 21, 2025 · Steve is a member of Equities Staff editorial team. He brings 22 years of investment publishing experience to the table having worked at MarketWatch most of his career.

Feb 5, 2025 · Paula is an award winning business development and marketing executive who optimizes people, resources and products to achieve ambitious goals.

Jan 29, 2025 · On his second day in office, President Donald Trump pledged up to $500 billion in investment in artificial intelligence as part of a new partnership formed by OpenAI, Oracle and SoftBank.. The ...

4 days ago · Featuring news, education and solutions that make it easier for advisors and fund managers to reach and service NextGen investors who are set to inherit the majority of the $84T in great wealth ...

Aug 21, 2024 · Equities.com Disclaimer. Equities.com is a media platform and is not in the business of effecting transactions in securities for the account of others.

We believe in the power of collaboration to drive innovation and change. Our partner program is designed to create mutually beneficial relationships with companies that share our vision and values.

Nov 5, 2024 · The Forbes Advisor editors provided these tips for investors doing their own due diligence to help them find ESG funds that align with their investment goals and values:

Feb 6, 2025 · Now that the year is underway and a new presidential administration is in place in Washington, let’s consider the environment for mergers and acquisitions (M&A) in the pharmaceutical industry.

Feb 28, 2025 · Chuck Jaffe is a columnist at MarketWatch and the host of “Money Life with Chuck Jaffe” and the author of 3 books. With 40 years of experience as a financial journalist, Chuck has produced ...

Jan 6, 2025 · 2024 was quite a year for significant strategic action among the pharmaceutical giants. Here are five key trends that will carry forward into 2025: